$BHR
Braemar Hotels & Resorts Inc. Stock $bhr

$bhr Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000157408524000099 Filed on May 09, 2024

Income Statement

Concept	2024 Q2	2024 Q1
Revenue	$187.6M	$219.1M
YoY Change	0.47%	1.75%
Cost Of Revenue	$58.16M	$60.08M
YoY Change	3.3%	-3.56%
Gross Profit	$129.4M	$159.0M
YoY Change	-0.75%	3.92%
Gross Profit Margin	69.0%	72.58%
Selling, General & Admin	$84.74M	$84.42M
YoY Change	3.03%	-0.38%
% of Gross Profit	65.47%	53.09%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$24.69M	$25.42M
YoY Change	9.43%	12.87%
% of Gross Profit	19.08%	15.99%
Operating Expenses	$117.3M	$116.5M
YoY Change	3.75%	1.15%
Operating Profit	$12.18M	$42.47M
YoY Change	-29.97%	12.35%
Interest Expense	-$25.97M	-$24.81M
YoY Change	27.62%	17.19%
% of Operating Profit	-213.32%	-58.43%
Other Income/Expense, Net
YoY Change
Pretax Income	-$13.90M	$16.93M
YoY Change	332.65%	-10.56%
Income Tax	-$114.0K	$1.452M
% Of Pretax Income		8.57%
Net Earnings	-$11.57M	$15.93M
YoY Change	526.49%	-0.65%
Net Earnings / Revenue	-6.17%	7.27%
Basic Earnings Per Share	-$0.33	$0.05
Diluted Earnings Per Share	-$0.33	$0.05
COMMON SHARES
Basic Shares Outstanding	66.48M shares	66.52M shares
Diluted Shares Outstanding	66.50M shares	268.5M shares

Balance Sheet

Concept	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$114.6M	$137.1M
YoY Change	-10.48%	-51.31%
Cash & Equivalents	$114.6M	$137.1M
Short-Term Investments
Other Short-Term Assets	$4.929M	$11.27M
YoY Change	-72.88%	27.66%
Inventory	$4.634M	$4.681M
Prepaid Expenses
Receivables	$32.41M	$41.00M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$156.6M	$194.0M
YoY Change	-14.98%	-43.03%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.800B	$1.876B
YoY Change	-4.8%	-0.21%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$1.540M	$1.625M
YoY Change	-9.36%	-5.25%
Other Assets	$177.3M	$82.45M
YoY Change	179.22%	30.74%
Total Long-Term Assets	$2.055B	$2.087B
YoY Change	-1.07%	0.89%
TOTAL ASSETS
Total Short-Term Assets	$156.6M	$194.0M
Total Long-Term Assets	$2.055B	$2.087B
Total Assets	$2.212B	$2.281B
YoY Change	-2.2%	-5.32%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$129.7M	$144.2M
YoY Change	-4.02%	11.32%
Accrued Expenses	$19.11M	$60.30M
YoY Change	-68.43%	-0.53%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$161.4M	$220.3M
YoY Change	-23.42%	7.89%
LONG-TERM LIABILITIES
Long-Term Debt	$1.128B	$1.223B
YoY Change	-0.66%	-4.26%
Other Long-Term Liabilities	$137.2M	$22.90M
YoY Change	505.13%	0.78%
Total Long-Term Liabilities	$1.266B	$1.246B
YoY Change	9.24%	-4.17%
TOTAL LIABILITIES
Total Short-Term Liabilities	$161.4M	$220.3M
Total Long-Term Liabilities	$1.266B	$1.246B
Total Liabilities	$1.427B	$1.466B
YoY Change	4.21%	-2.53%
SHAREHOLDERS EQUITY
Retained Earnings	-$437.3M	-$412.0M
YoY Change	28.16%	26.84%
Common Stock	$665.0K	$664.0K
YoY Change	0.91%	0.76%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$282.3M	$307.3M
YoY Change
Total Liabilities & Shareholders Equity	$2.212B	$2.281B
YoY Change	-2.2%	-5.32%

Cashflow Statement

Concept	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income	-$11.57M	$15.93M
YoY Change	526.49%	-0.65%
Depreciation, Depletion And Amortization	$24.69M	$25.42M
YoY Change	9.43%	12.87%
Cash From Operating Activities	$24.12M	$36.04M
YoY Change	22.74%	-14.83%
INVESTING ACTIVITIES
Capital Expenditures	$15.89M	$23.33M
YoY Change	-9.15%	24.73%
Acquisitions
YoY Change
Other Investing Activities	$38.00K	$504.0K
YoY Change	-67.8%	-2200.0%
Cash From Investing Activities	-$15.85M	-$22.83M
YoY Change	-8.75%	21.88%
FINANCING ACTIVITIES
Cash Dividend Paid		$13.12M
YoY Change		3.9%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-46.63M	$39.71M
YoY Change	-69.99%	653.06%
NET CHANGE
Cash From Operating Activities	24.12M	$36.04M
Cash From Investing Activities	-15.85M	-$22.83M
Cash From Financing Activities	-46.63M	$39.71M
Net Change In Cash	-38.36M	$52.92M
YoY Change	-74.94%	83.39%
FREE CASH FLOW
Cash From Operating Activities	$24.12M	$36.04M
Capital Expenditures	$15.89M	$23.33M
Free Cash Flow	$8.225M	$12.71M
YoY Change	281.49%	-46.18%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	60298000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	60379000	usd
CY2024Q1	us-gaap	Other Liabilities OtherLiabilities	22895000	usd
CY2023Q4	us-gaap	Other Liabilities OtherLiabilities	22756000	usd
CY2024Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	0	usd
CY2023Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	12000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	1466450000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	1408298000	usd
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q1	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	33005000	usd
CY2023Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	32395000	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	80000000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	80000000	shares
CY2024Q1	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	16000	usd
CY2023Q4	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	16000	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	664000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	666000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	718498000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-412013000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-412199000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	307273000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	306981000	usd
CY2024Q1	us-gaap	Minority Interest MinorityInterest	-9677000	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	-8934000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	297596000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	298047000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2281432000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2226824000	usd
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	66636353	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	66636353	shares
CY2024Q1	us-gaap	Assets Assets	2281432000	usd
CY2023Q4	us-gaap	Assets Assets	2226824000	usd
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	1223277000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	1162444000	usd
CY2024Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	144240000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	149867000	usd
CY2024Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	9253000	usd
CY2023Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	9158000	usd
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	66477431	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	66477431	shares
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	718606000	usd
CY2024Q1	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	136033000	usd
CY2023Q1	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	136097000	usd
CY2024Q1	bhr	Property Taxes Insurance And Other PropertyTaxesInsuranceAndOther	10685000	usd
CY2023Q1	bhr	Property Taxes Insurance And Other PropertyTaxesInsuranceAndOther	8116000	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	25420000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	22521000	usd
CY2024Q1	bhr	Advisory Services Fee AdvisoryServicesFee	6700000	usd
CY2023Q1	bhr	Advisory Services Fee AdvisoryServicesFee	7948000	usd
CY2024Q1	bhr	General And Administrative Expense Credit GeneralAndAdministrativeExpenseCredit	-2226000	usd
CY2023Q1	bhr	General And Administrative Expense Credit GeneralAndAdministrativeExpenseCredit	2820000	usd
CY2024Q1	us-gaap	Costs And Expenses CostsAndExpenses	176612000	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	177502000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	42467000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	37799000	usd
CY2024Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-49000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-73000	usd
CY2024Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	796000	usd
CY2023Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	2108000	usd
CY2024Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	26491000	usd
CY2023Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	22873000	usd
CY2024Q1	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	721000	usd
CY2023Q1	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	12000	usd
CY2024Q1	us-gaap	Gains Losses On Extinguishment Of Debt Before Write Off Of Deferred Debt Issuance Cost GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost	0	usd
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt Before Write Off Of Deferred Debt Issuance Cost GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost	2318000	usd
CY2024Q1	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	932000	usd
CY2023Q1	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-334000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	16934000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	18933000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1452000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2329000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	15482000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	16604000	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossAttributableToNonredeemableNoncontrollingInterest	-743000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossAttributableToNonredeemableNoncontrollingInterest	309000	usd
CY2024Q1	us-gaap	Noncontrolling Interest In Net Income Loss Operating Partnerships Redeemable NoncontrollingInterestInNetIncomeLossOperatingPartnershipsRedeemable	296000	usd
CY2023Q1	us-gaap	Noncontrolling Interest In Net Income Loss Operating Partnerships Redeemable NoncontrollingInterestInNetIncomeLossOperatingPartnershipsRedeemable	261000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	15929000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	16034000	usd
CY2024Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	10407000	usd
CY2023Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	10350000	usd
CY2024Q1	us-gaap	Redeemable Preferred Stock Dividends RedeemablePreferredStockDividends	1998000	usd
CY2023Q1	us-gaap	Redeemable Preferred Stock Dividends RedeemablePreferredStockDividends	2454000	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	3524000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	3230000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	66455000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	66498000	shares
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	268516000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	72478000	shares
CY2024Q1	us-gaap	Profit Loss ProfitLoss	15482000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	16604000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	15482000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	16604000	usd
CY2024Q1	bhr	Comprehensive Income Loss Net Of Tax Portion Attributable To Nonredeemable Noncontrolling Interest ComprehensiveIncomeLossNetOfTaxPortionAttributableToNonredeemableNoncontrollingInterest	-743000	usd
CY2023Q1	bhr	Comprehensive Income Loss Net Of Tax Portion Attributable To Nonredeemable Noncontrolling Interest ComprehensiveIncomeLossNetOfTaxPortionAttributableToNonredeemableNoncontrollingInterest	309000	usd
CY2024Q1	bhr	Comprehensive Income Loss Net Of Tax Portion Attributable To Redeemable Noncontrolling Interest ComprehensiveIncomeLossNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest	296000	usd
CY2023Q1	bhr	Comprehensive Income Loss Net Of Tax Portion Attributable To Redeemable Noncontrolling Interest ComprehensiveIncomeLossNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest	261000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	15929000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	16034000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	298047000	usd
CY2024Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	369000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	472000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	3000	usd
CY2024Q1	bhr	Temporary Equity Stock Issued During Period Value Restricted Stock Award Gross TemporaryEquityStockIssuedDuringPeriodValueRestrictedStockAwardGross	32000	usd
CY2024Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.05
CY2024Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	3345000	usd
CY2024Q1	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	15186000	usd
CY2024Q1	us-gaap	Increase In Carrying Amount Of Redeemable Preferred Stock IncreaseInCarryingAmountOfRedeemablePreferredStock	1998000	usd
CY2024Q1	bhr	Redemption Value Adjustment RedemptionValueAdjustment	7000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	297596000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	393763000	usd
CY2023Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	19250000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	805000	usd
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.05
CY2023Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	3334000	usd
CY2023Q1	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	2024000	usd
CY2023Q1	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	16343000	usd
CY2023Q1	us-gaap	Increase In Carrying Amount Of Redeemable Preferred Stock IncreaseInCarryingAmountOfRedeemablePreferredStock	2454000	usd
CY2023Q1	bhr	Redemption Value Adjustment RedemptionValueAdjustment	4000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	377551000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	15482000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	16604000	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	25420000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	22521000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1127000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2213000	usd
CY2024Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	248000	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	188000	usd
CY2024Q1	us-gaap	Gains Losses On Extinguishment Of Debt Before Write Off Of Deferred Debt Issuance Cost GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost	0	usd
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt Before Write Off Of Deferred Debt Issuance Cost GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost	2318000	usd
CY2024Q1	bhr	Amortization Of Loan Costs And Capitalized Default Interest AmortizationOfLoanCostsAndCapitalizedDefaultInterest	1404000	usd
CY2023Q1	bhr	Amortization Of Loan Costs And Capitalized Default Interest AmortizationOfLoanCostsAndCapitalizedDefaultInterest	447000	usd
CY2024Q1	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	721000	usd
CY2023Q1	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	12000	usd
CY2024Q1	bhr	Depreciation And Amortization Excluding Intangible Assets DepreciationAndAmortizationExcludingIntangibleAssets	119000	usd
CY2023Q1	bhr	Depreciation And Amortization Excluding Intangible Assets DepreciationAndAmortizationExcludingIntangibleAssets	119000	usd
CY2024Q1	bhr	Amortization Of Non Refundable Membership Initiation Fees AmortizationOfNonRefundableMembershipInitiationFees	496000	usd
CY2023Q1	bhr	Amortization Of Non Refundable Membership Initiation Fees AmortizationOfNonRefundableMembershipInitiationFees	410000	usd
CY2024Q1	bhr	Interest Expense Accretion On Refundable Membership Club Deposits InterestExpenseAccretionOnRefundableMembershipClubDeposits	165000	usd
CY2023Q1	bhr	Interest Expense Accretion On Refundable Membership Club Deposits InterestExpenseAccretionOnRefundableMembershipClubDeposits	178000	usd
CY2024Q1	us-gaap	Gain Loss On Derivative Instruments Held For Trading Purposes Net GainLossOnDerivativeInstrumentsHeldForTradingPurposesNet	932000	usd
CY2023Q1	us-gaap	Gain Loss On Derivative Instruments Held For Trading Purposes Net GainLossOnDerivativeInstrumentsHeldForTradingPurposesNet	-334000	usd
CY2024Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-49000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-73000	usd
CY2024Q1	bhr	Deferred Tax Expense Benefit DeferredTaxExpenseBenefit	5000	usd
CY2023Q1	bhr	Deferred Tax Expense Benefit DeferredTaxExpenseBenefit	37000	usd
CY2024Q1	bhr	Increase Decrease In Accounts Receivable And Inventories IncreaseDecreaseInAccountsReceivableAndInventories	2194000	usd
CY2023Q1	bhr	Increase Decrease In Accounts Receivable And Inventories IncreaseDecreaseInAccountsReceivableAndInventories	-6473000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2327000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3453000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	564000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-731000	usd
CY2024Q1	bhr	Increase Decrease In Operating Lease Right Of Use Asset IncreaseDecreaseInOperatingLeaseRightOfUseAsset	147000	usd
CY2023Q1	bhr	Increase Decrease In Operating Lease Right Of Use Asset IncreaseDecreaseInOperatingLeaseRightOfUseAsset	141000	usd
CY2024Q1	bhr	Increase Decrease In Due To Related Parties Excluding Amounts Due To Affiliates IncreaseDecreaseInDueToRelatedPartiesExcludingAmountsDueToAffiliates	163000	usd
CY2023Q1	bhr	Increase Decrease In Due To Related Parties Excluding Amounts Due To Affiliates IncreaseDecreaseInDueToRelatedPartiesExcludingAmountsDueToAffiliates	-13000	usd
CY2024Q1	bhr	Increase Decrease In Due To From Third Party Hotel Managers IncreaseDecreaseInDueToFromThirdPartyHotelManagers	-5653000	usd
CY2023Q1	bhr	Increase Decrease In Due To From Third Party Hotel Managers IncreaseDecreaseInDueToFromThirdPartyHotelManagers	6859000	usd
CY2024Q1	us-gaap	Increase Decrease In Due To Affiliates IncreaseDecreaseInDueToAffiliates	1638000	usd
CY2023Q1	us-gaap	Increase Decrease In Due To Affiliates IncreaseDecreaseInDueToAffiliates	-7314000	usd
CY2024Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-81000	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-72000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	470000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	426000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	36039000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	42314000	usd
CY2024Q1	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	504000	usd
CY2023Q1	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	75000	usd
CY2024Q1	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0	usd
CY2023Q1	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	99000	usd
CY2024Q1	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	23332000	usd
CY2023Q1	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	18706000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-22828000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-18730000	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	62000000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	usd
CY2024Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	0	usd
CY2023Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	54250000	usd
CY2024Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	3244000	usd
CY2023Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	404000	usd
CY2024Q1	us-gaap	Payments For Derivative Instrument Financing Activities PaymentsForDerivativeInstrumentFinancingActivities	991000	usd
CY2023Q1	us-gaap	Payments For Derivative Instrument Financing Activities PaymentsForDerivativeInstrumentFinancingActivities	755000	usd
CY2024Q1	us-gaap	Proceeds From Derivative Instrument Financing Activities ProceedsFromDerivativeInstrumentFinancingActivities	1633000	usd
CY2023Q1	us-gaap	Proceeds From Derivative Instrument Financing Activities ProceedsFromDerivativeInstrumentFinancingActivities	1601000	usd
CY2024Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	18952000	usd
CY2024Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	13123000	usd
CY2023Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	12630000	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	98009000	usd
CY2024Q1	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	0	usd
CY2023Q1	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	2024000	usd
CY2024Q1	us-gaap	Payments For Repurchase Of Redeemable Noncontrolling Interest PaymentsForRepurchaseOfRedeemableNoncontrollingInterest	0	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Redeemable Noncontrolling Interest PaymentsForRepurchaseOfRedeemableNoncontrollingInterest	7039000	usd
CY2024Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	0	usd
CY2023Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	2024000	usd
CY2024Q1	us-gaap	Payments For Repurchase Of Preferred Stock And Preference Stock PaymentsForRepurchaseOfPreferredStockAndPreferenceStock	6566000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Preferred Stock And Preference Stock PaymentsForRepurchaseOfPreferredStockAndPreferenceStock	307000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	39709000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5273000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	52920000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	28857000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	166503000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	315696000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	219423000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	344553000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	22747000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	30283000	usd
CY2024Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-183000	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2024Q1	bhr	Dividends And Distributions Declared But Not Paid DividendsAndDistributionsDeclaredButNotPaid	9253000	usd
CY2023Q1	bhr	Dividends And Distributions Declared But Not Paid DividendsAndDistributionsDeclaredButNotPaid	8756000	usd
CY2024Q1	bhr	Stock Repurchase Accrued But Not Paid StockRepurchaseAccruedButNotPaid	369000	usd
CY2023Q1	bhr	Stock Repurchase Accrued But Not Paid StockRepurchaseAccruedButNotPaid	352000	usd
CY2024Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	15810000	usd
CY2023Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	6047000	usd
CY2024Q1	bhr	Accrued Preferred Stock Offering Expense AccruedPreferredStockOfferingExpense	0	usd
CY2023Q1	bhr	Accrued Preferred Stock Offering Expense AccruedPreferredStockOfferingExpense	80000	usd
CY2024Q1	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	865000	usd
CY2023Q1	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	843000	usd
CY2024Q1	bhr	Proceeds From Derivative Instrument Unsettled ProceedsFromDerivativeInstrumentUnsettled	399000	usd
CY2023Q1	bhr	Proceeds From Derivative Instrument Unsettled ProceedsFromDerivativeInstrumentUnsettled	596000	usd
CY2024Q1	bhr	Noncash Common Stock Unit Dividends NoncashCommonStockUnitDividends	35000	usd
CY2023Q1	bhr	Noncash Common Stock Unit Dividends NoncashCommonStockUnitDividends	0	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	85599000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	261541000	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	80904000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	54155000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	166503000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	315696000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	137051000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	281490000	usd
CY2024Q1	us-gaap	Restricted Cash RestrictedCash	82372000	usd
CY2023Q1	us-gaap	Restricted Cash RestrictedCash	63063000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	219423000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	344553000	usd
CY2024Q1	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	16	hotel
CY2024Q1	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	16	hotel
CY2024Q1	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	7	state
CY2024Q1	us-gaap	Number Of Units In Real Estate Property NumberOfUnitsInRealEstateProperty	4201	room
CY2024Q1	bhr	Number Of Units In Real Estate Property Net Partnership Interest NumberOfUnitsInRealEstatePropertyNetPartnershipInterest	3963	room
CY2024Q1	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	16	hotel
CY2024Q1	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	16	hotel
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Use of Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—The preparation of these condensed consolidated financial statements in accordance with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</span></div>
CY2024Q1	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	16	hotel
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	219079000	usd
CY2023Q1	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	16	hotel
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	215301000	usd
CY2024Q1	us-gaap	Land Land	630842000	usd
CY2023Q4	us-gaap	Land Land	630842000	usd
CY2024Q1	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	1544944000	usd
CY2023Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	1535501000	usd
CY2024Q1	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	171402000	usd
CY2023Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	166673000	usd
CY2024Q1	us-gaap	Construction In Progress Gross ConstructionInProgressGross	28550000	usd
CY2023Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	36954000	usd
CY2024Q1	us-gaap	Rental Properties RentalProperties	12746000	usd
CY2023Q4	us-gaap	Rental Properties RentalProperties	12746000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2388484000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2382716000	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	512215000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	498508000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1876269000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1884208000	usd
CY2024Q1	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	0	usd
CY2023Q1	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	0	usd
CY2024Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1235043000	usd
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1173043000	usd
CY2024Q1	bhr	Debt Instrument Capitalized Default Interest And Late Fees DebtInstrumentCapitalizedDefaultInterestAndLateFees	52000	usd
CY2023Q4	bhr	Debt Instrument Capitalized Default Interest And Late Fees DebtInstrumentCapitalizedDefaultInterestAndLateFees	120000	usd
CY2024Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	10395000	usd
CY2023Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	9135000	usd
CY2024Q1	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	1423000	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	1584000	usd
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	1223277000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	1162444000	usd
CY2024Q1	bhr	Secured Overnight Financing Rate Sofr Rate SecuredOvernightFinancingRateSOFRRate	0.0533
CY2023Q4	bhr	Secured Overnight Financing Rate Sofr Rate SecuredOvernightFinancingRateSOFRRate	0.0535
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt Before Write Off Of Deferred Debt Issuance Cost GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost	2300000	usd
CY2024Q1	bhr	Fair Value Consideration Threshold For Transfer In Out Of Level3 FairValueConsiderationThresholdForTransferInOutOfLevel3	0.10
CY2024Q1	bhr	Maturity Period Of Cash And Cash Equivalents Maximum MaturityPeriodOfCashAndCashEquivalentsMaximum	P90D
CY2024Q1	bhr	Indebtedness Fair Value Percent Variance From Carrying Value IndebtednessFairValuePercentVarianceFromCarryingValue	0.960
CY2023Q4	bhr	Indebtedness Fair Value Percent Variance From Carrying Value IndebtednessFairValuePercentVarianceFromCarryingValue	0.960
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	15929000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	16034000	usd
CY2024Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	10407000	usd
CY2023Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	10350000	usd
CY2024Q1	us-gaap	Redeemable Preferred Stock Dividends RedeemablePreferredStockDividends	1998000	usd
CY2023Q1	us-gaap	Redeemable Preferred Stock Dividends RedeemablePreferredStockDividends	2454000	usd
CY2024Q1	bhr	Undistributed Net Income Loss Allocated To Common Stockholders UndistributedNetIncomeLossAllocatedToCommonStockholders	177000	usd
CY2023Q1	bhr	Undistributed Net Income Loss Allocated To Common Stockholders UndistributedNetIncomeLossAllocatedToCommonStockholders	-104000	usd
CY2024Q1	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	3501000	usd
CY2023Q1	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	3185000	usd
CY2024Q1	bhr	Noncontrolling Interest In Net Income Loss Operating Partnerships Redeemable Inclusive Of Deemed Dividends NoncontrollingInterestInNetIncomeLossOperatingPartnershipsRedeemableInclusiveOfDeemedDividends	0	usd
CY2023Q1	bhr	Noncontrolling Interest In Net Income Loss Operating Partnerships Redeemable Inclusive Of Deemed Dividends NoncontrollingInterestInNetIncomeLossOperatingPartnershipsRedeemableInclusiveOfDeemedDividends	261000	usd
CY2024Q1	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Diluted ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted	12902000	usd
CY2023Q1	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Diluted ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted	3446000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	66455000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	66498000	shares
CY2024Q1	bhr	Incremental Common Shares Attributable To Dilutive Effect Of Assumed Conversion Of Operating Partnership Units IncrementalCommonSharesAttributableToDilutiveEffectOfAssumedConversionOfOperatingPartnershipUnits	0	shares
CY2023Q1	bhr	Incremental Common Shares Attributable To Dilutive Effect Of Assumed Conversion Of Operating Partnership Units IncrementalCommonSharesAttributableToDilutiveEffectOfAssumedConversionOfOperatingPartnershipUnits	5980000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	268516000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	72478000	shares
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
CY2024Q1	bhr	Net Income Loss Attributable To Antidilutive Securities NetIncomeLossAttributableToAntidilutiveSecurities	3621000	usd
CY2024Q1	bhr	Franchise Agreement Gross Rooms Revenue Percentage Current Period FranchiseAgreementGrossRoomsRevenuePercentageCurrentPeriod	0.03
CY2023Q1	bhr	Net Income Loss Attributable To Antidilutive Securities NetIncomeLossAttributableToAntidilutiveSecurities	13138000	usd
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	45980000	shares
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	129954000	shares
CY2024Q1	us-gaap	Noncontrolling Interest In Net Income Loss Operating Partnerships Redeemable NoncontrollingInterestInNetIncomeLossOperatingPartnershipsRedeemable	296000	usd
CY2023Q1	us-gaap	Noncontrolling Interest In Net Income Loss Operating Partnerships Redeemable NoncontrollingInterestInNetIncomeLossOperatingPartnershipsRedeemable	261000	usd
CY2024Q1	bhr	Cash Distributions Declared CashDistributionsDeclared	366000	usd
CY2023Q1	bhr	Cash Distributions Declared CashDistributionsDeclared	361000	usd
CY2024Q1	us-gaap	Dividends Common Stock DividendsCommonStock	3345000	usd
CY2023Q1	us-gaap	Dividends Common Stock DividendsCommonStock	3334000	usd
CY2024Q1	bhr	Related Party Transaction Base Fee112th Of Sum Of Market Capitalization And Net Asset Fee Adjustment RelatedPartyTransactionBaseFee112thOfSumOfMarketCapitalizationAndNetAssetFeeAdjustment	0.0070
CY2024Q1	bhr	Related Party Transaction Minimum Base Fee RelatedPartyTransactionMinimumBaseFee	0.90
CY2024Q1	bhr	Related Party Transaction Term Of Advisory Agreement RelatedPartyTransactionTermOfAdvisoryAgreement	P3Y
CY2020Q4	bhr	Contribution Agreement Preferred Equity Offering ContributionAgreementPreferredEquityOffering	400000000	usd
CY2024Q1	bhr	Maximum Project Management Fee As Percentage Of Project Cost MaximumProjectManagementFeeAsPercentageOfProjectCost	0.04
CY2024Q1	bhr	Advisory Agreement Architecture Fees AdvisoryAgreementArchitectureFees	0.065
CY2024Q1	bhr	Advisory Agreement Construction Management Fees AdvisoryAgreementConstructionManagementFees	0.10
CY2024Q1	bhr	Advisory Agreement Interior Design Fees AdvisoryAgreementInteriorDesignFees	0.06
CY2024Q1	bhr	Advisory Agreement Ffe Purchasing Fees AdvisoryAgreementFFEPurchasingFees	0.08
CY2024Q1	bhr	Advisory Agreement Ffe Purchasing Fees Freight And Tax Threshold AdvisoryAgreementFFEPurchasingFeesFreightAndTaxThreshold	2000000	usd
CY2024Q1	bhr	Advisory Agreement Ffe Purchasing Fees With Freight And Tax Threshold AdvisoryAgreementFFEPurchasingFeesWithFreightAndTaxThreshold	0.06
CY2024Q1	bhr	Advisory Agreement Ffe Purchasing Fees Freight And Tax Threshold AdvisoryAgreementFFEPurchasingFeesFreightAndTaxThreshold	2000000	usd
CY2024Q1	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	16	hotel
CY2024Q1	bhr	Number Of Hotels Under Franchise Agreement NumberOfHotelsUnderFranchiseAgreement	1	hotel
CY2024Q1	bhr	Franchise Agreement Expiration Period FranchiseAgreementExpirationPeriod	P25Y
CY2024Q1	bhr	Franchise Agreement Gross Rooms Revenue Percentage Year One Through Three FranchiseAgreementGrossRoomsRevenuePercentageYearOneThroughThree	0.03
CY2024Q1	bhr	Franchise Agreement Gross Rooms Revenue Percentage Year Four FranchiseAgreementGrossRoomsRevenuePercentageYearFour	0.04
CY2024Q1	bhr	Franchise Agreement Gross Rooms Revenue Percentage After Year Four FranchiseAgreementGrossRoomsRevenuePercentageAfterYearFour	0.05
CY2024Q1	us-gaap	Loss Contingency New Claims Filed Number LossContingencyNewClaimsFiledNumber	2	lawsuit
CY2024Q1	bhr	Loss Contingency Cases Consolidated Number LossContingencyCasesConsolidatedNumber	2	case
CY2024Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
bhr-20240331_cal.xml	Edgar Link	unprocessable
0001574085-24-000099-index-headers.html	Edgar Link	pending
0001574085-24-000099-index.html	Edgar Link	pending
0001574085-24-000099.txt	Edgar Link	pending
0001574085-24-000099-xbrl.zip	Edgar Link	pending
bhr-20240331.htm	Edgar Link	pending
bhr-20240331.xsd	Edgar Link	pending
bhr2024q110-qxex311.htm	Edgar Link	pending
bhr2024q110-qxex312.htm	Edgar Link	pending
bhr2024q110-qxex321.htm	Edgar Link	pending
bhr2024q110-qxex322.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
bhr-20240331_def.xml	Edgar Link	unprocessable
bhr-20240331_lab.xml	Edgar Link	unprocessable
bhr-20240331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
bhr-20240331_htm.xml	Edgar Link	completed
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BHR
Braemar Hotels & Resorts Inc. Stock $bhr

2024 Q2 Form 10-Q Financial Statement

#000157408524000099 Filed on May 09, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BHR Braemar Hotels & Resorts Inc. Stock $bhr

2024 Q2 Form 10-Q Financial Statement

#000157408524000099 Filed on May 09, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BHR
Braemar Hotels & Resorts Inc. Stock $bhr